Interaction Details

There were no interactions found between Durvalumab and Anhydrous Crystalline Maltose. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about combining Durvalumab and Anhydrous Crystalline Maltose? Ask Dr. Brian Staiger about it by contacting him directly.

Anhydrous Crystalline Maltose Overview

Anhydrous Crystalline Maltose Anhydrous crystalline maltose, a disaccharide composed of two D-glucose molecules connected by an alpha (1→4) bond, is produced from starch and used as a food stabilizer and desiccant in various industries. It is also simply known as 'malt sugar'. Orally, it is used for Sjogren syndrome and dry mouth associated with cancer chemotherapy or other medications. Research suggests that dissolving lozenges containing anhydrous crystalline maltose in the mouth can improve measures of unstimulated saliva volume in some patients with Sjogren syndrome. A variety of studies have reported that doses of up to 600 mg/day can be used safely for up to 24 weeks. Maltose, consisting of two glucose molecules, is less sweet than table sugar (sucrose), which is a combination of glucose and fructose.
See More Information Regarding Anhydrous Crystalline Maltose

Durvalumab Overview

  • Durvalumab is used alone to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. It is also used in combination with tremelimumab-actl (Imjudo) and platinum-based chemotherapy to treat a certain type of NSCLC that has spread throughout the lungs and to other parts of the body. Durvalumab injection is also used in combination with chemotherapy agents to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body. It is also used in combination with chemotherapy agents to treat biliary tract cancer (BTC; cancer in the organs and ducts that make and store bile, the liquid made by the liver) in adults whose cancer has spread to nearby tissues or to other parts of the body. Durvalumab is also used in combination with tremelimumab-actl to treat hepatocellular carcinoma (HCC; a type of liver cancer) that cannot be treated with surgery. Durvalumab injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.

See More Information Regarding Durvalumab Injection

Anhydrous Crystalline Maltose - More Interactions

Anhydrous Crystalline Maltose interacts with 84 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown No interactions have been reported or no interaction data is currently available.

Return to the main herbal interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.

Ask A Pharmacist About Your Herbal Questions!

Dr. Brian Staiger, PharmD

In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!

Ask A Pharmacist